Alternatives to KaliVir Immunotherapeutics, Inc.
KaliVir Immunotherapeutics, Inc. is a Biotechnology tool: clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment. Here are the 2 closest alternatives, compared on pricing, features and what real users say.
KaliVir Immunotherapeutics, Inc. profileMore Biotechnology alternatives
The 2 closest alternatives to KaliVir Immunotherapeutics, Inc.
Ranked by how closely each one overlaps with KaliVir Immunotherapeutics, Inc. on category and features.
- 1
Developing novel immunotherapies and diagnostics for cancer.
- Pricing:
- Contact for pricing
- Reddit:
- 100% positive(6 mentions)how we count
- 2
Spark Therapeutics
BiotechnologyA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Pricing:
- Contact for pricing
- Reddit:
- 33% positive(3 mentions)how we count
Community sentiment is our own count of how positive, negative or neutral the discussions we track about each tool are, across the subreddits where its users actually post. It is not a star rating and it is not a review score. Pricing reflects each vendor's public plans and can change, so check the provider for the current price.
We track only 2 close alternatives to KaliVir Immunotherapeutics, Inc. so far. Browse more Biotechnology alternatives while this list fills out.
The 20 closest Biotechnology companies to KaliVir Immunotherapeutics, Inc.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website ImmunoScape58BiotechnologySingapore, Singapore$49.7M
Developing novel immunotherapies and diagnostics for cancer.
- Website Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8M
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Showing the 20 closest matches. See the rest on the KaliVir Immunotherapeutics, Inc. profile.
KaliVir Immunotherapeutics, Inc. alternatives: common questions
What are the closest alternatives to KaliVir Immunotherapeutics, Inc.?
ImmunoScape, Spark Therapeutics are the closest alternatives to KaliVir Immunotherapeutics, Inc. by feature overlap and category. Each one is compared above on pricing, features and community sentiment.
Compare KaliVir Immunotherapeutics, Inc. head to head
Side by side on what each one does, what it costs, and what real users report.